全文获取类型
收费全文 | 3462篇 |
免费 | 204篇 |
国内免费 | 66篇 |
专业分类
耳鼻咽喉 | 26篇 |
儿科学 | 137篇 |
妇产科学 | 13篇 |
基础医学 | 508篇 |
口腔科学 | 14篇 |
临床医学 | 514篇 |
内科学 | 728篇 |
皮肤病学 | 7篇 |
神经病学 | 12篇 |
特种医学 | 66篇 |
外科学 | 313篇 |
综合类 | 570篇 |
预防医学 | 266篇 |
眼科学 | 8篇 |
药学 | 365篇 |
4篇 | |
中国医学 | 78篇 |
肿瘤学 | 103篇 |
出版年
2024年 | 4篇 |
2023年 | 37篇 |
2022年 | 96篇 |
2021年 | 155篇 |
2020年 | 129篇 |
2019年 | 106篇 |
2018年 | 98篇 |
2017年 | 89篇 |
2016年 | 101篇 |
2015年 | 107篇 |
2014年 | 244篇 |
2013年 | 235篇 |
2012年 | 216篇 |
2011年 | 223篇 |
2010年 | 162篇 |
2009年 | 143篇 |
2008年 | 164篇 |
2007年 | 153篇 |
2006年 | 131篇 |
2005年 | 130篇 |
2004年 | 108篇 |
2003年 | 76篇 |
2002年 | 79篇 |
2001年 | 78篇 |
2000年 | 63篇 |
1999年 | 68篇 |
1998年 | 69篇 |
1997年 | 61篇 |
1996年 | 52篇 |
1995年 | 57篇 |
1994年 | 51篇 |
1993年 | 34篇 |
1992年 | 33篇 |
1991年 | 27篇 |
1990年 | 32篇 |
1989年 | 23篇 |
1988年 | 24篇 |
1987年 | 11篇 |
1986年 | 12篇 |
1985年 | 17篇 |
1984年 | 13篇 |
1983年 | 5篇 |
1982年 | 5篇 |
1981年 | 5篇 |
1980年 | 1篇 |
1979年 | 2篇 |
1978年 | 1篇 |
1976年 | 1篇 |
1974年 | 1篇 |
排序方式: 共有3732条查询结果,搜索用时 15 毫秒
91.
Diagnosis of invasive pulmonary aspergillosis (IPA) is a challenging process in immunocompromised patients. Galactomannan (GM) antigen detection in bronchoalveolar lavage (BAL) fluid is a method to detect IPA with improved sensitivity over conventional studies. We sought to determine the diagnostic yield of BAL GM assay in a diverse population of immunocompromised patients. A retrospective review of 150 fiberoptic bronchoscopy (FOB) with BAL for newly diagnosed pulmonary infiltrate in immunocompromised patients was performed. Patient information, procedural details and laboratory studies were collected. BAL and serum samples were evaluated for GM using enzyme‐linked immunoassay. Of 150 separate FOB with BAL, BAL GM was obtained in 143 samples. There were 31 positive BAL GM assays. In those 31 positive tests, 13 were confirmed as IPA, giving a positive predictive value of 41.9%. There was one false negative BAL GM. Of the 18 false positive BAL GM, 4 were receiving piperacillin–tazobactam and 11 were receiving an alternative beta‐lactam antibiotic. BAL GM assay shows excellent sensitivity for diagnosing IPA. There was a significant number of false positive BAL GM assays and several of those patients were receiving beta‐lactam antibiotics at the time of bronchoscopy. 相似文献
92.
93.
《Respiratory investigation》2020,58(6):479-487
BackgroundSome patients with sarcoidosis experience worsening of pulmonary lesions. However, no biomarker has been identified that reflects pulmonary disease status in sarcoidosis. We investigated the usefulness of potential markers of pulmonary fibrosis in patients with sarcoidosis.MethodsPlasma matrix metalloproteinase 7 (MMP-7), CC-chemokine ligand 18 (CCL-18), and periostin levels were evaluated in 60 patients with sarcoidosis and 30 healthy controls; bronchoalveolar lavage fluid levels were analyzed in 22 patients with sarcoidosis. To determine the usefulness of these markers, we explored potential correlations between these markers and sarcoidosis clinical characteristics.ResultsPlasma MMP-7, CCL-18, and periostin concentrations were significantly higher in patients with sarcoidosis than those in healthy controls. MMP-7 concentrations in plasma and bronchoalveolar lavage fluid were higher in patients with sarcoidosis with parenchymal infiltration than in those without lung lesions. Moreover, MMP-7 concentration was negatively correlated with pulmonary function.ConclusionAmong these novel biomarkers, MMP-7 most precisely reflected pulmonary sarcoidosis disease status and thus, might be useful for diagnosing and evaluating sarcoidosis, particularly in patients with pulmonary parenchymal lesions. 相似文献
94.
《Respiratory investigation》2020,58(3):131-133
Recent advances using molecular methods, matrix-assisted laser desorption ionization time of flightmass spectrometry, and next-generation sequencers enable rapid and precise detection of bacterial species in the clinical samples, revealing bacterial diversities in the human body. Corynebacterium species are Gram-positive bacilli, which can cause pneumonia and have been reported as causative pathogens of lower respiratory tract infections since the 1970's. However, Corynebacterium spp. may be recognized and sorted as part of normal respiratory flora on Gram staining and culture, resulting in clinical under-recognition as pathogenic bacteria.The results of the clone library method using bacterial 16S ribosomal RNA gene sequence analysis in Japanese patients with hospital-acquired pneumonia revealed that bronchoalveolar lavage fluid obtained from the lung lesions contained 11.8% Corynebacterium spp., which was the second most predominant bacterial phylotype. Additionally, among patients in whom Corynebacterium spp. were detected, C. simulans was most commonly detected followed by C. striatum. In addition, almost half of the patients in whom C. simulans was detected was monophylotypic infection and/or co-detection of C. simulansand C. striatum. Further clinical information is expected on corynebacteria as pathogens of lower respiratory tract infection. 相似文献
95.
96.
Mohamed Rafiq Gollapalle Lakshminarayanashastry Viswanatha Dattatray Anturlikar Suryakanth Mohammed Azeemuddin Mahalingaiah Jagadeesh Krishna Dhanush Pralhad Sadashiv Patki 《Scientia pharmaceutica》2013,81(3):833-842
In the present study, the protective effect of Bresol® – a polyherbal formulation – was evaluated in an experimental model of cigarette smoke (CS)-induced COPD in rats. Ten minutes daily exposure to CS for 7 weeks caused significant elevation of TNF-α (p<0.01) and total protein (p<0.01) in the bronchoalveolar lavage fluid (BALF) of positive untreated control animals, indicating ongoing inflammatory process in the lungs. Further, histopathological findings have confirmed the presence of pathological lesions in the trachea and lungs. Five weeks of post-treatment with Bresol® (250 and 500 mg/kg, p.o.) showed significant and dose-dependent anti-inflammatory effects against CS-induced lung abnormalities by maintaining the TNF-α and total protein levels within the normal range. Additionally, Bresol®-treated animals showed normal cyto-architecture of the trachea and lungs. In conclusion, Bresol® showed dose-dependent protection against CS-induced lung and tracheal injury in rats, which further indicates, Bresol® is a useful healing agent, may help to decelerate the progression of COPD, and reduce the exacerbations in patients. 相似文献
97.
Qi Qiao Xiong Liu Ting Yang Kexin Cui Li Kong Conglian Yang Zhiping Zhang 《药学学报(英文版)》2021,11(10):3060-3091
Acute respiratory distress syndrome (ARDS) is characterized by the severe inflammation and destruction of the lung air–blood barrier, leading to irreversible and substantial respiratory function damage. Patients with coronavirus disease 2019 (COVID-19) have been encountered with a high risk of ARDS, underscoring the urgency for exploiting effective therapy. However, proper medications for ARDS are still lacking due to poor pharmacokinetics, non-specific side effects, inability to surmount pulmonary barrier, and inadequate management of heterogeneity. The increased lung permeability in the pathological environment of ARDS may contribute to nanoparticle-mediated passive targeting delivery. Nanomedicine has demonstrated unique advantages in solving the dilemma of ARDS drug therapy, which can address the shortcomings and limitations of traditional anti-inflammatory or antioxidant drug treatment. Through passive, active, or physicochemical targeting, nanocarriers can interact with lung epithelium/endothelium and inflammatory cells to reverse abnormal changes and restore homeostasis of the pulmonary environment, thereby showing good therapeutic activity and reduced toxicity. This article reviews the latest applications of nanomedicine in pre-clinical ARDS therapy, highlights the strategies for targeted treatment of lung inflammation, presents the innovative drug delivery systems, and provides inspiration for strengthening the therapeutic effect of nanomedicine-based treatment. 相似文献
98.
目的通过对类风湿关节炎(RA)患者进行高分辨CT(HRCT)和肺泡灌洗液检测(BLAF),探讨诊断类风湿肺间质病变的有效方法。方法选择RA患者31例,进行高分辨CT、肺泡灌洗液检测。结果 31例患者中,HRCT检测发现肺间质病变1例(阳性率为3.2%),BLAF检测发现肺间质病变4例(阳性率为12.9%);BLAF的肺间质病变阳性检出率高于HRCT,但差异无统计学意义(χ2=1.957 9,P〉0.05)。结论 BLAF是探询早期发现及明确类风湿性关节炎引发呼吸系统损害的更为有效的检查方法,比HRCT能更好地明确肺间质病变病变的病理类型,有助于治疗方案的制定。 相似文献
99.
支气管肺泡灌洗是用液体直接灌注,将支气管、肺泡内的分泌物、积滞物通过稀释、吸引迅速排除,起到了类似外科清创、引流排毒的作用,并以此缓解气道阻塞、改善呼吸功能、控制感染。该项技术在肺部疾病的诊断和治疗应用方面已成为主要手段之一。由于该项技术较为安全且相对无损伤,在肺科领域得到了较为广泛的应用,并日益受到临床的高度重视。该文对支气管肺泡灌洗术在小儿肺部疾病方面的临床应用研究进展进行了综述。 相似文献
100.
Young pigs were immunized with the lung-pathogenic bacterium Actinobacillus (Haemophilus) pleuropneumoniae by aerosol or orally using viable and inactivated bacteria. The cellular changes in the bronchoalveolar lavage (BAL) were studied in repeated lavages after the pigs were infected with live bacteria. The nucleated cells in the BAL were differentiated and lymphocyte subsets determined. There were no major differences between the two routes of immunization or between viable and inactivated bacteria. The immunization induced an increase in all lymphocyte subsets studied and in the appearance of plasma cells and lymphoid blasts. The infection did not cause a further increase except in granulocytes. The lack of a booster-type increase in lymphocytes in the BAL might indicate a different immunologic reaction of the lung or that lymphocytes of the BAL do not represent lung lymphocytes in general. The protective effect of the immunization might be deduced from the increase in lymphocytes after immunization but not from the reaction pattern after infection.
Offprint requests to: R. Pabst 相似文献